Work
PDUFA VII goals letter (FY 2023–2027)
The FDA's performance goals and procedures for the 2022 renewal of the prescription drug user fees, agreed after talks with industry.
- Dates
- 2022
Connections 1
author
- U.S. Food and Drug Administration Primary record 1
Timeline 1 date
- 2022 PDUFA VII goals letter (FY 2023–2027)
Proof 1 source
-
PDUFA Reauthorization Performance Goals and Procedures, Fiscal Years 2023 through 2027, U.S. Food and Drug Administration.
Primary record
The goals letter represents the product of FDA’s discussions with the regulated industry and public stakeholders, as mandated by Congress.
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.